GYY4137

Catalog No.S9920 Batch:S992003

Technical Data

Formula	C₁₁H₁₆NO₂PS₂.C₄H₉NO
Molecular Weight	376.47	CAS No.	106740-09-4
Solubility (25°C)*	In vitro	DMSO	75 mg/mL (199.21 mM)
		Water	25 mg/mL (66.4 mM)
		Ethanol	Insoluble
* <1 mg/ml means slightly soluble or insoluble. * Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. * Room temperature shipping (Stability testing shows this product can be shipped without any cooling measures.)

Preparing Stock Solutions

Biological Activity

Description

GYY4137 is a novel, water-soluble hydrogen sulfide (H2S)–releasing molecule with vasodilator and antihypertensive activity. GYY4137 shows potent anti-hepatocellular carcinoma activity through blocking the STAT3 pathway. GYY4137 also shows anti-inflammatory activity.

Targets

STAT3 ^[2]

In vitro

GYY4137 (400-800 µM) causes concentration-dependent killing of seven different human cancer cell lines (HeLa, HCT-116, Hep G2, HL-60, MCF-7, MV4-11 and U2OS) but does not affect survival of normal human lung fibroblasts (IMR90, WI-38).^[4]

In vivo

In the complete Freund's adjuvant (CFA)-treated mouse, GYY4137 injected 1 hr prior to CFA increased knee joint swelling while an anti-inflammatory effect, as demonstrated by reduced synovial fluid myeloperoxidase (MPO) and N-acetyl-β-D-glucosaminidase (NAG) activity and decreased TNF-α, IL-1β, IL-6 and IL-8 concentration, is apparent when GYY4137 was injected 6 hrs after CFA.^[3]

Protocol (from reference)

Cell Assay:^{^[4]}	Cell lines HeLa, HCT-116, Hep G2, HL-60, MCF-7, MV4-11 and U2OS Concentrations 400 µM, 800 µM Incubation Time 5 days, 8 days Method Live cell incubated with GYY4137(400 or 800 µM) are collected after 5 days and counted in triplicate after staining with trypan blue using a haemocytometer for cell viability assay. The generation of H2S from GYY4137(400 µM) is determined in aliquots (100 µl) withdrawn at timed intervals (up to 7 days) from cultured MCF-7 cells maintained in Dulbecco's modified Eagle's medium.
Animal Study:^{^[3]}	Animal Models Complete Freund Dosages 50 mg/kg Administration i.p.

Cell Assay:^{^[4]}

Cell lines
HeLa, HCT-116, Hep G2, HL-60, MCF-7, MV4-11 and U2OS
Concentrations
400 µM, 800 µM
Incubation Time
5 days, 8 days
Method
Live cell incubated with GYY4137(400 or 800 µM) are collected after 5 days and counted in triplicate after staining with trypan blue using a haemocytometer for cell viability assay. The generation of H2S from GYY4137(400 µM) is determined in aliquots (100 µl) withdrawn at timed intervals (up to 7 days) from cultured MCF-7 cells maintained in Dulbecco's modified Eagle's medium.

Animal Study:^{^[3]}

Animal Models
Complete Freund
Dosages
50 mg/kg
Administration
i.p.

References

[4] Lee ZW, et al. PLoS One. 2011;6(6):e21077.

+ Expand

RETURN POLICY
Selleck Chemical’s Unconditional Return Policy ensures a smooth online shopping experience for our customers. If you are in any way unsatisfied with your purchase, you may return any item(s) within 7 days of receiving it. In the event of product quality issues, either protocol related or product related problems, you may return any item(s) within 365 days from the original purchase date. Please follow the instructions below when returning products.

SHIPPING AND STORAGE
Selleck products are transported at room temperature. If you receive the product at room temperature, please rest assured, the Selleck Quality Inspection Department has conducted experiments to verify that the normal temperature placement of one month will not affect the biological activity of powder products. After collecting, please store the product according to the requirements described in the datasheet. Most Selleck products are stable under the recommended conditions.

NOT FOR HUMAN, VETERINARY DIAGNOSTIC OR THERAPEUTIC USE.